retatrutide 4mg - “Triple G” New retatrutide Phase 3 data

Scientists are now exploring whether therapies originally developed for type 2 diabetes and obesity may influence inflammation, neuronal survival, and the progression of neurodegenerative disorders

Common side effects include stomach upset, nausea, vomiting, constipation, and decreased appetite (FDA, 2017)

Since compounded Semaglutide GLP-1 can vary in formulation due to different compounding pharmacies, its effectiveness may differ

Some Akkermansia strains exhibit antibiotic resistance, which raises theoretical concerns about gene transfer in clinical settings

Judk P, Esposito S, Coppieters G, Van Eenoo P, Deventer K